In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...
While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...
Half a million people in the UK are now thought to be using weight-loss injections such as Mounjaro and Wegovy — and business is booming. Novo Nordisk, which makes Wegovy, has seen sales of its ...
Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...
14h
Whoopi Goldberg wants fans to know that the ad circulating on Instagram appearing to show her endorsing a weight loss drug is ...
Ozempic and Wegovy maker Novo Nordisk quieted Wall Street's concerns with its fourth-quarter results and 2025 outlook.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback